Ratcliffe Liam

Director at ARVN; Director at ARRAY BIOPHARMA INC

Sold, on record
$71.6M
Dollars the filings state
Form 4 sales
6
Latest Dec 16, 2021
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
2
Plan not stated
0
No plan
4
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. Dec 16, 2021Unusual

    ARVN

    Sold 65.7% of their holdings

    $23.8M355,705 shares at $67.00

    Filed Dec 16, 2021Form 4

  2. Nov 15, 2021Plan not stated

    ARVN

    Sold 19.9% of their holdings

    $11.5M134,310 shares at $85.83

    Filed Nov 15, 2021Form 4

  3. Nov 9, 2021Unusual

    ARVN

    Sold 100% of their holdings

    $16M172,079 shares at $93.02

    Filed Nov 9, 2021Form 4

  4. Sep 27, 2013Unusual

    ARRAY BIOPHARMA INC

    Sold 100% of their holdings

    $6.8M1.1M shares at $6.00

    Filed Sep 30, 2013Form 4

  5. Sep 16, 2013Unusual

    ARRAY BIOPHARMA INC

    Sold 59.8% of their holdings

    $10.2M1.7M shares at $6.08

    Filed Sep 16, 2013Form 4

  6. Sep 6, 2013Plan not stated

    ARRAY BIOPHARMA INC

    Sold 17.1% of their holdings

    $3.3M577,286 shares at $5.79

    Filed Sep 6, 2013Form 4

6 of 6

Every transaction

Loading transactions…

Sales and notices (6)

Form 144 notices and Form 4 sales by Ratcliffe Liam
Source
Dec 16, 2021Dec 16, 2021ARVNDirectorForm 4 sale355,705$23.8M65.7%UnusualSEC
Nov 15, 2021Nov 15, 2021ARVNDirectorForm 4 sale134,310$11.5M19.9%Plan not statedSEC
Nov 9, 2021Nov 9, 2021ARVNDirectorForm 4 sale172,079$16M100.0%UnusualSEC
Sep 27, 2013Sep 30, 2013ARRAY BIOPHARMA INCDirectorForm 4 sale1.1M$6.8M100.0%UnusualSEC
Sep 16, 2013Sep 16, 2013ARRAY BIOPHARMA INCDirectorForm 4 sale1.7M$10.2M59.8%UnusualSEC
Sep 6, 2013Sep 6, 2013ARRAY BIOPHARMA INCDirectorForm 4 sale577,286$3.3M17.1%Plan not statedSEC